NINTH INTERNATIONAL CONFERENCE ON GENE THERAPY OF CANCER

第九届国际癌症基因治疗会议

• 批准号: 6228815
• 负责人: ROBERT E SOBOL
• 金额: $ 1万
• 依托单位: SIDNEY KIMMEL CANCER CENTER
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-09-01 至 2001-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6228815
• 关键词: gene therapy; international health /scientific organization; meeting /conference /symposium; neoplasm /cancer therapy; travel

The proposed conference is the ninth international conference devoted exclusively to gene therapy of cancer. Leading researchers from around the world will present the latest results of their basic research, pre-clinical and clinical studies of cancer treatment using gene therapy technology. The design of the program includes sessions focusing on treatment resistance and sensitization gene therapy; tumor suppressor, apoptosis, angiogenesis and anti-oncogene therapy; and cytokine and tumor immunotherapy. Each topic session will begin with an overview of the field and the current status of human clinical trials. Also featured will be a workshop on vector systems and targeting. Invited speakers will be followed by the presentation of proffered abstracts describing recent basic research, pre- clinical, and clinical data. There will be an afternoon devoted to discussion sessions with additional oral and poster presentations from submitted abstracts. This conference will be of interest to clinical oncologists, molecular biologists, cellular biologists, tumor immunologists and other interested health professionals and researchers working in this field.

这是第九次专门讨论癌症基因治疗的国际会议。 来自世界各地的领先研究人员将展示他们利用基因治疗技术治疗癌症的基础研究、临床前和临床研究的最新成果。 该计划的设计包括侧重于治疗抗性和致敏基因治疗的会议;肿瘤抑制，凋亡，血管生成和抗癌基因治疗;和细胞因子和肿瘤免疫治疗。 每一个主题会议将开始与该领域的概述和人体临床试验的现状。 还将举办一个关于病媒系统和目标选择的讲习班。受邀演讲者之后将介绍提供的摘要，描述最近的基础研究、临床前和临床数据。 将有一个下午专门用于讨论会，并对提交的摘要进行额外的口头和海报介绍。本次会议将是感兴趣的临床肿瘤学家，分子生物学家，细胞生物学家，肿瘤免疫学家和其他感兴趣的卫生专业人员和研究人员在这一领域的工作。